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Introduction
In the literature on headache epidemiology [1], the majori-
ty of studies have been descriptive, giving data on the dis-
tribution of headache prevalence and the resulting burden
and cost among different groups. More recently, analytic
epidemiologic studies with the explicit aim of studying cau-
sation by considering whether the risk of headache is dif-
ferent for those exposed and not exposed to some factor of
interest have been performed. The present paper will focus
on some important methodological issues in headache epi-
demiology, discuss the relative merits of different method-
ologic designs and the main sources of error, and finally
outline the current challenges for headache epidemiology.
Methodology
Case definition, or how to define who has headache (is a case) and
who has not, is a problem because headache diagnoses usually are
made on the basis of subjective experiences without any objective
signs or markers. Even the term “headache” can be ambiguous,
and higher headache prevalence will be found in answer to a neu-
tral question (“do you have headache?”) than to questions involv-
ing some specification of headache degree (e.g., “do you suffer
from headache?” or “do you have severe headache?”) [2]. This is
important when a question about headache is used to screen out
non-headache sufferers before the more specific questions about
the features of the various headache types are posed. Headache
diagnoses are ultimately dependent on self-report, and the quality
of recall is of crucial importance. Recall problems may explain
why those who answer “no” to the screening question about
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headache may nevertheless suffer from headache, even migraine
[3]. In addition, cultural differences related to the threshold for
reporting pain may contribute to variation in headache prevalence
in different regions or over time.
To define the various headache subtypes, most epidemiolog-
ic studies have used the criteria of the International Headache
Society (IHS) from 1988, or the revision from 2004
(International Classification of Headache Disorders, 2nd edition
(ICHD-2)), but often with some modifications. The way these
criteria are applied may give rise to large variations in preva-
lence. Recent studies from the USA [4] and France [5] indicate
that the migraine prevalence will almost double if not only strict
migraine (ICHD-2, 1.1 and 1.2) but also probable migraine
(ICHD-2, 1.6) are counted as migraine.
It is also a problem that multiple headache types often coex-
ist in the same individuals. In the classification it is required that
each headache occurring in the same individual gets a separate
diagnosis and that secondary causes of headache are excluded.
The extent to which multiple headaches can be diagnosed is
highly dependent on the method of data collection. To make reli-
able diagnoses of several coexisting headaches, including the
rare primary or secondary headaches, it is necessary that a per-
sonal interview and examination is performed by a neurologist
using the diagnostic criteria (the “gold-standard” method). This
approach is expensive and has been used in only a few popula-
tion studies [6, 7]. However, secondary causes of headache are
uncommon in the general population [8], and multiple headache
types are of less importance when the study aim is to identify
only migraine or tension-type headache (TTH) sufferers.
Screening by other health personnel (nurses, medical students)
or instructed lay persons has been shown to be accurate when
the aim is to identify only the most common headache types.
Telephone interviews may enable diagnosis of more than one of
the primary headaches, whereas this has proved to be very diffi-
cult with questionnaires. In questionnaire studies, the partici-
pants are often asked to give an answer based on the overall most
distressing headache type. A recognition-based method, giving
descriptions of migraine and TTH based on the IHS criteria to
the participants, has been found to be quite reliable for mass
screening of migraine and TTH among adolescents [9].
In many headache epidemiologic studies it is necessary not
only to define a case (headache) group but also a control (refer-
ence) group. As headache is experienced at least occasionally by
the great majority of the population, it is hard to find a control
group without headache. It may be better to define a reference
group with minor headache complaints, e.g., including persons
with infrequent TTH (ICHD-2).
As headache usually varies considerably through life, it is
important to define the time frame for the headache. Lifetime
prevalence measures the lifetime occurrence of headache. One-
year prevalence is often used because it is considered reasonably
reliable, and it defines the proportion of the population that has an
active disease, therefore being relevant for assessing the burden of
headache in society. The three-month prevalence gives similar
information, and probably also studies not specifying a time frame,
only asking a question like “do you suffer from headache?”. In
general, it is highly advisable to specify a time frame, and most
studies to date have been done with the one-year prevalence.
Validation of the diagnostic method to estimate the degree of
agreement (sensitivity, specificity, positive and negative predic-
tive values) between the method applied and the gold-standard
method in a random sample of participants should be performed
in most headache epidemiologic studies [10]. A validation study
should be done even if the questionnaire has already been vali-
dated, as one method may not be valid in other regions or coun-
tries, or at another time.
Defining the source population, i.e. the population from
which study participants are drawn, is important for the repre-
sentativeness of the study. Samples from a country, region, city or
smaller community may be representative for the whole popula-
tion, and primary school students for their age group, whereas
patients, university students or company employees are probably
not representative. To obtain a representative group the sampling
method is also important. If the whole population cannot be stud-
ied, a random sample of the population will most probably yield
a representative group, or one may use a stratified sample to
ensure that the studied group is similar to the source population
with regard to e.g., age, gender and socioeconomic status.
Even if the source population and sampling methods are ade-
quate, the study population may still not be representative if par-
ticipation in the study is low and some groups are more likely to
participate than others. If headache is the main object of the
study, individuals suffering from headache may be more likely to
participate than non-headache sufferers, and headache preva-
lence may be overrated. Likewise, if certain age or socioeco-
nomic groups have a higher non-participation rate than the aver-
age, this may distort the results. It is usually desirable that an
evaluation of the non-participants is performed to assess
whether they are different from the participating population with
regard to demographic variables, or the participating population
can be compared e.g., to census data for the country or town in
which the study takes place. If participation is found to vary sub-
stantially by demographic characteristics, prevalence rates can
be adjusted to compensate for differential participation.
Types of epidemiologic studies
In a case series, headache is described and often related to
some other factor in a group of patients, e.g., occurrence
of migraine attacks have been related to meteorological
factors [11] or the menstrual cycle [12]. In addition, sev-
eral studies have described the prevalence and special fea-
tures of migraine and headache in patients with other dis-
orders, e.g., Tourette syndrome [13] or idiopathic intracra-
nial hypertension [14]. As there is no control group, only
hypotheses about causal factors can be formulated on the
basis of such studies.
With ecological (or correlational) studies, the
headache prevalence in a defined population is related to
some other factor, e.g., to employment rate in different
districts [15], or migraine prevalence related to altitude
[16]. A limitation of this method is that exposure cannot
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be linked to particular individuals, and that it is not possi-
ble to adjust for possible confounding factors.
In cross-sectional surveys, the disease status of indi-
viduals in the population is assessed at the same time as
exposures of interest, such as demographic factors,
comorbid conditions or other suspected risk factors. A
prevalence study is a cross-sectional study conducted to
determine the proportion of the population that has a dis-
ease. In virtually all prevalence studies in adults there is a
higher proportion of headache sufferers among women
than among men. Migraine prevalence typically increases
in childhood and youth, and is relatively stable and high in
the third to the fifth decade, after which there is a marked
decline in both sexes. TTH appears to be less related to
age than migraine. Prevalence studies have also given data
on attack frequencies, duration and severity. In addition,
the impact of headache on public health can be studied by
adding questions about influence on work and leisure
activities, absenteeism etc.
If a study is repeated on the same individuals, it is pos-
sible to calculate headache incidence, i.e., the number of
new (“incident”) cases in a defined population, accumu-
lated over several years, or per time period (e.g. [17]).
Cross-sectional studies may also be used to assess associ-
ations between headache and suspected risk factors and
other disorders.
In case–control studies, a group of headache sufferers
is compared with a control group (healthy persons or indi-
viduals with some other disorders) with regard to either a
suspected cause or some other clinical features or factors.
An example is the study showing that body mass index
was higher and socioeconomic status lower among
patients with chronic daily headache than among those
with episodic headache [18]. The case–control method has
also been used to compare the prevalence of headache
among subjects with or without another disorder, e.g., that
headache was more prevalent among patients referred for
polysomnography for obstructive sleep apnoea than
among controls [19].
A limitation of case-control and cross-sectional studies
for studying causation is that both disease and suspected
cause are measured at the same point in time. Hence, it is
not always certain that exposure to the risk factor of inter-
est preceded the onset of illness, particularly when con-
sidering exposures that change as a result of medication
[20]. This problem is overcome in cohort studies, in which
groups are selected on the basis of whether they have been
exposed to a suspected cause or not, before the onset of
illness, and they are subsequently monitored for the occur-
rence of the outcome of interest. It is important that
knowledge about the disease (headache) is not used to
define the cohorts, and disease status should be deter-
mined in a blinded manner without knowledge of prior
exposure status. Selective participation in the follow-up
dependent on exposure status may distort results in cohort
studies. In cohort studies, it has been demonstrated that
depression is a risk factor for migraine but not other
headaches after 2 years [21], but whiplash trauma or con-
cussion are not risk factors for headache 1 year or more
after the trauma [22, 23]. Similarly, headache and
migraine have been found to be risk factors for incident
stroke in several cohorts [24, 25].
The true association of a disorder to some exposure
may be distorted by bias and confounding. Selection bias
(related to who participates in the study as a case or con-
trol) can result from poor participation or sampling, mis-
diagnosis of disease status and loss to follow-up.
Information bias (related to the information about or mea-
surement of exposure) includes measurement problems
due to defective instrumentation, non-blinded investiga-
tors or differences in recall between groups.
A confounder is a third factor that can explain the
association between an exposure and a disorder, without
itself being on the causal chain between cause and effect.
Age, gender and socioeconomic status are important
potentially confounding factors in headache epidemiolog-
ic studies as well as for many other diseases.
The challenge for headache epidemiology
Epidemiologic studies have demonstrated that headache and
migraine are prevalent and entail a high burden on popula-
tions in many areas of the world, but we still need docu-
mentation from populous areas like China, India, Russia and
large parts of Africa. In addition, there are surprisingly few
studies on TTH, which is the most prevalent headache type.
Epidemiologic studies have demonstrated large varia-
tions in headache prevalence, not only across countries but
also over time in the same country. At present, it is hard to
determine whether these variations are real or due to
methodological differences, and to make meaningful com-
parisons between different studies it is necessary that the
methods in headache epidemiology are standardised. This
would have to include how to define the source population,
sampling, case ascertainment and phrasing of questions,
how to avoid biases and to deal with possible confounders.
It is a cause for concern that some recent studies indi-
cate an increase in headache prevalence over time, and
investigations to determine whether the increase is real or
whether it is apparent, due to changes in methodology or
the threshold for reporting headache in the population,
should have high priority. If real, headache epidemiology
could be the most important instrument to identify the
causes so that the trend can be changed.
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